As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

His mother, Amberlie Reinertsen, says Mason has had lung complications since birth but has never been this sick before.

Over a third of women giving birth got the new RSV vaccine in September, protecting newborns from severe illness. The new maternal Respiratory ...

Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t ...

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory ...